Advances in Non-Small Cell Lung Cancer (NSCLC) Treatment—A Paradigm Shift in Oncology-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Advances in Non-Small Cell Lung Cancer (NSCLC) Treatment—A Paradigm Shift in Oncology

Published:2024-02-13 Issue:2 Volume:17 Page:246
ISSN:1424-8247
Container-title:Pharmaceuticals
language:en
Short-container-title:Pharmaceuticals

Author:

Ali Azhar¹^ORCID

Affiliation:

1. Cancer Science Institute of Singapore, MD6, Center for Translational Medicine, #12-01, National University of Singapore, 14 Medical Drive, Singapore 117599, Singapore

Abstract

Non-Small Cell Lung Cancer (NSCLC) management remains a formidable challenge in the field of oncology, representing a significant global health burden [...]

Publisher

MDPI AG

Link

https://www.mdpi.com/1424-8247/17/2/246/pdf

Reference27 articles.

1. EGFR mutations in lung cancer: Correlation with clinical response to gefitinib therapy;Paez;Science,2004

2. Anaplastic lymphoma kinase: A glimmer of hope in lung cancer treatment?;Franco;Expert Rev. Anticancer Ther.,2013

3. Activation of MET via diverse exon 14 splicing alterations occurs in multiple tumor types and confers clinical sensitivity to MET inhibitors;Frampton;Cancer Discov.,2015

4. ROS1-dependent cancers—Biology, diagnostics and therapeutics;Drilon;Nat. Rev. Clin. Oncol.,2021

5. How far we have come targeting BRAF-mutant non-small cell lung cancer (NSCLC);Tabbo;Cancer Treat. Rev.,2022

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP